Recent Updates
Recently added Catalysts
KNSA Positive Sentiment

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference

Key Takeaway: Kiniksa Pharmaceuticals International, plc (KNSA) will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026. The presentation will be available via a live webcast on the company's website, with a replay accessible shortly after the event. Kiniksa focuses on developing therapies for unmet medical needs, particularly in cardiovascular diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kiniksa Pharmaceuticals is actively engaging with investors.
  • The company is presenting at a significant healthcare conference.
  • The event provides an opportunity for Kiniksa to showcase its innovations.

Full Press Release Details

LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Wells Fargo 21 st Annual Healthcare Conference on Wednesday, September 9, 2026 at 8:45 a.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ®

Kiniksa Investor & Media Contact Jonathan Kirshenbaum (781) 829-3949 jkirshenbaum@kiniksa.com

Frequently Asked Questions

When is Kiniksa's presentation at the conference?

Kiniksa's presentation is scheduled for September 9, 2026, at 8:45 a.m. ET.

How can I access the webcast of the presentation?

The live webcast can be accessed through the Investors section of Kiniksa's website.

Will there be a replay of the event?

Yes, a replay will be available on Kiniksa's website within approximately 48 hours after the event.

What is Kiniksa's focus in biopharmaceuticals?

Kiniksa focuses on developing therapies for diseases with unmet needs, particularly cardiovascular indications.

Last updated: Sep 4, 2026